Lys322
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteprivacy & cookiesCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Ubiquitylation Site Page:
Lys322 - ARCN1 (mouse)

Site Information
LHVENEDkKGVQLQT   SwissProt Entrez-Gene
Predicted information:  Scansite
Orthologous residues: ARCN1 (human): K322, ARCN1 (rat): (K322)
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 10837122

In vivo Characterization
Methods used to characterize site in vivo: mass spectrometry (1, 2, 3)
Disease tissue studied: testicular cancer (3)
Relevant cell line - cell type - tissue: ES-J1 (stem) (2), F9 (testicular) (3), PYS-2 (epithelial) (1)




References

1

Zhou J (2010) CST Curation Set: 9134; Year: 2010; Biosample/Treatment: cell line, PY2/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG)
Curated Info

2

Zhou J (2010) CST Curation Set: 9129; Year: 2010; Biosample/Treatment: cell line, ES J1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG)
Curated Info

3

Zhou J (2010) CST Curation Set: 9130; Year: 2010; Biosample/Treatment: cell line, F9/untreated; Disease: testicular cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG)
Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.